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Introduction
The fetus is increasingly being seen as a target for pre-
natal treatments such as stem cell transplantation and
gene therapy. At present, there are few indications to
access the fetal gastrointestinal tract for diagnosis or
therapy. However, genetic conditions such as cystic fi-
brosis (CF) and congenital enteropathies may be ame-
nable to prenatal cell or gene-based treatments through
minimally invasive techniques that could be clinically
applied during the early-gestation fetal immunologic
window [1].
The target organ for treatment of CF and congeni-
tal enteropathies is the small bowel. In 60% of CF
fetuses, thickened intestinal mucus and undigested
proteins block the small bowel, causing meconium ileus,
a life-threatening complication [2]. Adult CF patients
also suffer from recurrent episodes of pain, abdominal
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SUMMARY
Objective: Safely targeting the fetal gastrointestinal tract during early gestation is essential to develop effective
prenatal gene therapy for gastrointestinal diseases. In this study, we aimed to characterize the development of
the fetal sheep stomach sonographically and to determine the optimum gestational age, as well as the short-
term morbidity and mortality of early-gestation ultrasound-guided intragastric injection.
Materials and Methods: In experiments investigating ultrasound-guided prenatal gene therapy, we studied the
size and development of the stomach of 185 sheep fetuses (33–144 days’ gestational age [GA]; term is 145 days).
Ultrasound-guided intragastric injection was performed in 12 fetuses at 55–62 days’ GA and postmortem exami-
nations were performed 48 hours later.
Results: The stomach was not visible at or before 40 days’ GA, but it was seen in all fetuses at 55 days’ GA or
more. The anteroposterior, transverse and longitudinal diameters of the stomach increased in a quasi-linear
fashion throughout gestation. Intragastric injection was successful in 10 out of the 11 fetuses (91%) injected at
60–62 days’ GA, with nine fetuses (91%) surviving this procedure.
Conclusion: In the early-gestation sheep fetus, ultrasound-guided intragastric injection has a good success rate
with a low short-term mortality and morbidity. [Taiwan J Obstet Gynecol 2010;49(1):23–29]
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distension and bilious vomiting, called distal intestinal
obstruction syndrome [3]. However, delivering therapy
directly into the small bowel is difficult to achieve owing
to its small size. In the human fetus, for example, tiny
areas of fluid can be seen within the small bowel lumen
from 13 weeks’ gestational age (GA), but ultrasound-
guided injection would not be possible until 25 weeks’
GA, when the average diameter of the small bowel lumen
is 1.8 mm [4].
In sheep, as in all ruminants, the stomach is highly
specialized. It is composed of four chambers, the rumen,
reticulum, omasum and abomasum, through which
food passes successively during rumination (Figure 1).
Little is known about the ultrasonographic dimensions
and morphology of the stomach in the sheep fetus. It
has been suggested that the stomach in fetal sheep be-
comes visible under ultrasound somewhere between 40
and 65 days’ GA [5]; however, an exact time frame and
related stomach dimensions are not available. We stud-
ied the sonographic visibility of the fetal sheep stomach
throughout gestation and evaluated the intragastric
injection technique in early-gestation sheep fetuses to
determine the optimum time frame, the morbidity, and
the mortality of the procedure.
Materials and Methods
Biometry and morphology of the ovine fetal stomach
During experiments designed to investigate ultrasound-
guided prenatal gene therapy [6–11], 185 Romney sheep
fetuses underwent 238 ultrasonographic examinations
between 33 and 144 days’ GA (term is 145 days). Each
fetus was examined a maximum of two times. Ewes were
time-mated after receiving intravaginal progesterone
suppositories for 2 weeks to induce ovulation. General
anesthesia was induced with 1 g of thiopentone intra-
venously, and after intubation, the ewes were main-
tained on halothane 2% in oxygen. Transabdominal
ultrasound imaging was performed using a 3.5 MHz
probe on a Vingmed Sonotron CFM 800 (GE Vingmed
UltraSound, Horten, Norway) or an Acuson 128 XP10
ultrasound scanner (Siemens, Bracknell, UK). Fetal
biometry (biparietal diameter, occipito-snout length, ab-
dominal circumference, and femur length) was per-
formed to confirm GA according to published normal
range measurements [12,13].
The fetal stomach chambers were visualized in the
upper left abdomen, and the number of stomach cavi-
ties was documented. The widest anteroposterior (AP)
and transverse (T) diameters were measured in the axial
plane, and the widest longitudinal (L) diameter was
measured in the sagittal plane. Each diameter measured
included all the communicating stomach chambers that
were visible in that plane. In all measurements, the cal-
ipers were placed “inner-to-inner”. The presence of a
normally developed stomach was confirmed at post-
mortem analysis in all fetuses.
Injection of the fetal sheep stomach
Twelve Romney sheep fetuses between 55–62 days’ GA
were used in these experiments. Under general anesthe-
sia and after ultrasound measurement of the fetal stom-
ach, a 22-gauge Echotip spinal needle (Cook Ireland Ltd,
Limerick, Ireland) was inserted under ultrasound guid-
ance through the maternal skin, the uterus and into
the fetal stomach, avoiding passage through the pla-
centomes if possible. Correct needle placement was
confirmed by aspiration of 100 μL of gastric fluid after
which, adenovirus vectors containing the β-galactosidase
reporter gene (adenovirus-lacZ) [14] and transduction
enhancing agents [11] were injected under view. The
presence of microbubbles within the stomach cavities
was used to confirm correct fluid placement. The nee-
dle was then flushed through with 40 μL saline to clear
the needle dead space. The time taken to inject the
stomach cavity was measured from the first insertion
of the needle through the fetal skin to removal of the
needle from the fetus after successful delivery of vec-
tor and transduction enhancing agents. The ewes were
then allowed to recover after extubation. Following the
injection, fetal survival was monitored every 12 hours
for 2 days using ultrasound while the ewe was awake.
Two days after injection, the ewes were euthanized
using an overdose of intravenous pentobarbital so-
dium (Euthatal; Rhône Merieux, Essex, UK), a post-
mortem examination was performed and tissue samples
were processed as described previously [6]. All proce-
dures and ultrasound examinations were conducted 
in accordance with UK Home Office regulations and
the Guidance for the Operation of Animals (Scientific
Procedures) Act (1986).
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Figure 1. Chambers in a sheep’s stomach.
Results
Measurement of the fetal sheep stomach
The dimensions of the fetal stomach and the number
of visible chambers were documented in 190 and 211
examinations, respectively. The fetal stomach was not
visible in any fetus aged 40 days’ GA or less (n = 14). In
three fetuses aged between 45 and 50 days’ GA, the fetal
stomach was visible; but because of the small numbers,
no conclusions can be drawn. As of 50 days’ GA, more
data were available. Between 51 and 54 days’ GA, the
fetal stomach was visible in 43 out of 55 fetuses (78%)
as compared with 100% when the fetuses were examined
at or beyond 55 days’ GA (χ2 test, p value < 0.001).
The ability to visualize the stomach chambers was
studied throughout gestation. As gestation advanced,
more of the stomach chambers became visible (Table 1).
The fetal stomach dimensions increased in a quasi-linear
fashion from 45 to 144 days’ GA; the largest diameter at
any time point was the longitudinal diameter. Figure 2
shows the change in dimension of the AP, T and L
diameters of the stomach from 45 to 144 days’ GA.
Ultrasound-guided intragastric injection
We found injection at 55 days’ GA difficult owing to
the small cavity volume at this age (2.7 mm AP × 3 mm
T×5 mm L). In an attempt to inject the fetal sheep stom-
ach at this GA, the dimensions did not allow withdrawal
of gastric fluid into the syringe. Therefore, correct nee-
dle placement could not be confirmed. A 22-gauge nee-
dle tip was successfully advanced into the fetal stomach,
allowing fluid turbulence to be visualized, and micro-
bubbles were seen within the stomach lumen on instil-
lation of 100 μL saline and the viral vector. Fetal demise
was noted 12 hours after injection when postmortem
examination showed a large peritoneal blood clot ante-
rior to the liver and umbilical vein, and a smaller clot to
the right of the fetal rumen, suggesting iatrogenic death.
Bacteriologic culture of fetal tissues showed a moder-
ate growth of Campylobacter jejuni, a fleece commensal.
Because of the difficulty involved in injecting the fetal
stomach at 55 days’ GA and our observation that the
AP diameter was approaching 10 mm at 60 days’ GA, we
performed further stomach injections from this GA
onwards. Injection was attempted in 11 fetuses from
seven ewes at 60–62 days’ GA with success in 10 fetuses
(91%). In all cases, the needle was confirmed to be cor-
rectly positioned within the fetal stomach by withdrawal
of 100 μL of clear gastric fluid. In some of the fetuses,
we were able to demonstrate all four stomach cham-
bers after injection of an additional volume of fluid
(300–1,000 μL), compared with only two prior to injec-
tion, clearly demonstrating that the injected fluid passed
into the fetal stomach chambers distal to the injection
site (Figure 3). Evidence for definitive gene transfer to the
distal gastrointestinal tract in the surviving successfully
injected fetuses has been already presented elsewhere
[15]. One injection failure was in a triplet pregnancy, in
which the other two fetuses were successfully injected.
Visualization of the third triplet was poor owing to
fetal position, and the injection was abandoned after
failure of attempts to withdraw gastric fluid.
In most cases (eight out of 11 injections, 73%), the
fetus was positioned so that the needle transgressed
the abdominal cavity a short distance before entering
the stomach. In three cases, the fetus was lying on its
left side, meaning that to reach the stomach, the nee-
dle had to pass through the fetal liver. These cases
were not associated with failed injection, hemorrhage
or infection. Overall, the mean time to successful gas-
tric injection was 7 minutes, 21 seconds (standard
deviation, 6 minutes 44 seconds; range, 29 seconds to
13 minutes 34 seconds). In one twin fetal pair, the first
attempt at gastric injection failed owing to fetal posi-
tion, but a second attempt was successful in each case.
Intragastric injection was achieved at the first attempt
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Table 1. Development and visibility of the fetal sheep stomach chambers through gestation
GA range (d) n
Stomach chambers visible, n (%)
0 1 2 3 4
33–40 14 14 (100) 0 0 0 0
45–50 3 0 3 (100) 0 0 0
51–54 54 12 (22) 27 (50) 14 (26) 0 1 (2)
55–64 63 0 24 (38) 38 (60) 1 (2) 0
65–80 22 0 3 (14) 16 (72) 3 (14) 0
81–100 28 0 0 30 (11) 9 (32) 16 (57)
101–115 17 0 0 5 (29) 3 (18) 9 (53)
116–144 10 0 0 0 0 10 (100)
GA = gestational age.
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Figure 2. Dimensions of the fetal sheep stomach through
gestation. The error bars indicate ± one standard deviation.
AP = anteroposterior; GA = gestational age.
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Figure 3. Sonograms showing injection of fluid into the stomach of a fetal sheep at 60 days’ gestation. There was an increase
in the number of stomach chambers visible from (A) 2 days before injection to (B) 4 days after injection.
in eight fetuses (80% of successful injections) in a mean
time of 4 minutes 56 seconds (standard deviation, 
2 minutes 41 seconds; range, 29 seconds to 8 minutes
18 seconds).
There was one fetal death in the 11 injected fetuses at
60–62 days’ GA (91% survival). This occurred in a twin
gestation shortly after injection, in an experiment in
which both twins received gastric injection. Postmortem
analysis showed a large blood clot posterior to the
right lobe of the liver, extending to the left of the midline.
Culture of fetal tissues showed no evidence of bacterial
infection, and we concluded that the cause of death was
procedural rather than owing to iatrogenic infection.
Postmortem and histologic findings 2 days after 
vector injection are shown in Table 2. Clear ascitic fluid
was present in all nine fetuses who survived, and at a
larger volume than is normally present in the omentum
at this GA (50–100 μL). Measurement of the protein
content in four of the ascitic fluid samples confirmed 
a transudate. The volume observed was generally pro-
portional to the volume of fluid injected into the fetal
stomach cavity, and it is likely that this was fluid that
had leaked out of the stomach after injection. In the
fetus with the largest volume of ascites (8 mL), a small
pleural effusion (0.2 mL) was also observed. In another
fetus, filmy peritoneal adhesions were seen. Culture of
the fetal liver and ascites showed a pure growth of
coagulase-negative Staphylococcus that was most likely
introduced during the injection procedure.
Discussion
As a first step towards clinical application of prenatal
gene therapy for CF, we have characterized the 
ultrasonographic dimensions and morphology of the
ovine fetal stomach throughout gestation and evaluated
a minimally-invasive ultrasound-guided injection tech-
nique into the fetal stomach in a large animal model in
early gestation. We found that the fetal sheep stomach
could be reliably observed by ultrasound from 55 days’
GA. This is comparable to human pregnancy in which
the stomach could be seen using transabdominal ultra-
sound in 98% of fetuses from 14 weeks’ GA; indeed, an
inability to visualize the stomach at this age was asso-
ciated with an abnormal pregnancy outcome [16].
Transvaginal sonography in the human fetus permits
earlier visualization of the stomach from 9 weeks, with
the stomach being visible in almost all cases at 12 weeks’
GA. This is equivalent to 46 days’ GA in the fetal sheep
[17]. Transvaginal sonography has not been used in
fetal sheep, but it is likely that fetal anatomy would be
visible earlier in gestation using this method. Our study
would suggest, however, that even if the stomach were
visible, attempts to inject it might fail because of the
small size.
The widest diameters of the fetal sheep stomach
showed an almost linear increase during gestation. We
did not calculate the total volume of the fetal sheep
stomach throughout gestation, however, because of its
more complicated anatomy and design for rumination
in the sheep. In the human fetus, there is a wide variation
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Table 2. Postmortem and histologic findings after ultrasound-guided intragastric injection of the fetal sheep stomach
Vector and enhancing agents
Postmortem Histologic and
Age (d) AdlacZ 
DEAE- Sodium 
Perflubron
Ascites 
culture 
(p/kg)
dextran caprate 
(mL)
examination
(mL)
examination
(5 mg/mL) 100 mM (mL)
findings
62 1 × 1010 – 100 – No abnormality 1 No abnormality
60 1.6 × 1013 – – – No abnormality 2 No abnormality
61 1 × 1013 – 100 0.3 No abnormality 2 No abnormality
60 9.5 × 1012 + 100 0.3 No abnormality 2 No abnormality
60 1.4 × 1013 + 200 1.0 No abnormality 0.5 No abnormality 
60 1.0 × 1013 + 200 1.0 Fine peritoneal 1 Coagulase-negative 
adhesions Staphylococcus
cultured from
ascites
60 1.1 × 1013 + 200 1.0 No abnormality 6.5 No abnormality
60 1.1 × 1013 + 200 1.0 Fetal death; – Tissue autolysis, no 
peritoneal clot bacteria cultured
60 1.0 × 1013 + 200 1.5 No abnormality 3 No abnormality
60 8.8 × 1012 + 200 1.5 Small pleural 8 No abnormality
effusion
55 2 × 1011 – – – Fetal death; – Campylobacter jejuni
peritoneal clots cultured in some 
fetal tissues
60 Failed intragastric injection No abnormality 0.1 No abnormality
AdlacZ = adenovirus-lacZ; DEAE = diethylaminoethyl.
in stomach volume because of dynamic filling and emp-
tying [18]; but over long periods of evaluation, the
dimensions remain relatively constant [19]. Using three-
dimensional reconstruction from two-dimensional ultra-
sound measurement, the stomach volume has been
shown to increase linearly in the latter half of preg-
nancy [20]. The four chambers of the sheep stomach
develop at different rates over the GA range we stud-
ied. From 18 days’ GA, the primitive stomach is identifi-
able as an expansion of the foregut spindle in the early
sheep embryo, and the four chambers are discernible
anatomically by 26 days’ GA [21]. By 34 days’ GA, the
rumen and reticulum are clearly separated, with the
rumen on the left side of the abdominal cavity. Rapid
early expansion of the rumen pushes the omasum and
abomasum to the right of the abdominal cavity, and by
the end of the embryonic period, the position and rel-
ative sizes of the chambers are the same as in the adult
with the rumen comprising around 75% of the stomach
volume. In the second half of gestation, the abomasum
expands preferentially, so that at birth, it accounts for
more than half of stomach volume. This is because fer-
mentation is unnecessary in the suckling neonate. Ru-
minal growth only catches up after birth on weaning
and the relative sizes of the chambers reach that of the
adult again by 1 year of age. It is most likely that the one
or two chambers visible sonographically in early gesta-
tion represented the reticulorumen, and the enlarging
abomasum and omasum most probably were the third
and fourth chambers seen later in gestation or after gas-
tric distension that are noted caudal and to the right
of the reticulorumen on longitudinal views of the fetus
(Figure 3B).
We found that intragastric injection was best
achieved from 60 days’ GA, when the AP diameter was
approaching an average of 10 mm. This is still below
70–72 of 145 days’ GA, after which the fetal sheep im-
mune system becomes significantly less tolerant to a
foreign antigen [1]. Intragastric injection was achieved
in all but one case complicated by a triplet pregnancy
and in a relatively short procedure time. An advantage
of the technique is that the needle position could be
confirmed by withdrawal of a small volume of gastric
fluid. The needle position was also confirmed when nee-
dle advancement within the cavity was associated with
fluid turbulence, and microbubbles were clearly seen
within the stomach lumen during fluid instillation. The
appearance of additional stomach chambers during
injection is another sign of a successful injection; how-
ever, this sign was not consistently observed in all of
the successfully injected cases.
The short-term morbidity and mortality from the
procedure were low. The position of the fetus did not
appear to affect the outcome of the procedure, but
larger numbers of injections are needed to confirm this
finding. In a clinical setting, the risk of trauma to in-
traperitoneal organs might be reduced by injecting the
fetal stomach only when it is positioned uppermost
and closest to the uterine wall. It is likely that procedures
would be done without maternal or fetal sedation, and
therefore, the injection could be performed when the
fetus had moved into the optimum position. We per-
formed postmortem and histologic analysis 2 days after
injection, but longer-term follow up, including allowing
some lambs to deliver, is necessary to evaluate the ef-
fect of intragastric injection on the development of the
fetal stomach and its function in postnatal life. As antic-
ipated, we observed hemorrhagic and infective compli-
cations. Peritonitis and intraperitoneal adhesions are
likely to be the most common complications.
There is one published study of ultrasound-guided
intragastric injection of late-gestation fetal rabbits [22].
The authors successfully injected the stomach in 70%
(18/26) of cases. This was lower than our success rate of
91% (10 out of 11 cases) and may be because of the
double needle technique that the authors used in which
they placed a 20-gauge spinal needle into the fetal ab-
dominal cavity and then advanced a 26-gauge needle
through this into the fetal stomach. Their short-term
survival rate (91%) was good, and there was no histo-
logic evidence of trauma or hemorrhage in the survivors.
In summary, we have characterized the ultrasono-
graphic appearance and dimensions of the fetal sheep
stomach during gestation and have shown that the fetal
sheep stomach can be reached by ultrasound-guided
injection in the early gestation, pre-immune fetus with
minimal trauma and low short-term mortality. Our find-
ings, combined with effectiveness in achieving a wide-
spread fetal gene transfer to the gastrointestinal tract
and a similar ontogeny of human and ovine fetal gut
peristalsis and gastric acid secretion [15], suggest that
clinically applicable studies in the fetal sheep are appro-
priate for the development of prenatal gene therapy of
congenital diseases that affect the gastrointestinal tract.
Despite differences in stomach anatomy, the shape and
size of the fetal sheep rumen in early gestation is very
similar to that of the stomach in the human fetus [19].
We anticipate, therefore, that injection of the stomach
in the human fetus would be just as straightforward.
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